HELIX
Performance

Tamoxifen (Nolvadex)

Also known as Nolvadex, Tamoxifen Citrate

A SERM that is FDA-approved for breast cancer and widely used in performance circles to prevent or treat gynecomastia and to restore natural testosterone in post-cycle therapy.

Typical dosing
10–20 mg · Daily (oral)
Administration
Oral
Half-life
~5-7 days
Level
intermediate

How it works

Antagonizes estrogen receptors in breast tissue and the hypothalamus (while acting as an agonist in bone and liver), increasing gonadotropins.

Benefits

  • Blocks estrogen at breast tissue (prevents/reverses gyno)
  • Raises LH/FSH and testosterone in PCT
  • Oral

Dosing

10–20 mg · Daily (oral)

Gyno/PCT use is typically 10-20 mg/day; higher acute doses are sometimes used for active gyno.

Ranges reflect commonly cited research protocols, not a prescription. Dose with a licensed provider.

Common stacks

ClomipheneHCG

Reported side effects

  • Hot flashes
  • Mood changes
  • Nausea
  • Reduced IGF-1
  • Rare clotting risk

Who it’s for

Those managing estrogenic side effects or running PCT, ideally with clinic guidance.

Track Tamoxifen (Nolvadex) in Helix

Dose reminders, reconstitution math, vial tracking, and AI guidance — free on iOS.

Download free

RELATED COMPOUNDS